Fulgent Gross Profit from 2010 to 2024

FLGT Stock  USD 20.70  0.35  1.72%   
Fulgent Genetics Gross Profit yearly trend continues to be comparatively stable with very little volatility. Gross Profit is likely to outpace its year average in 2024. Gross Profit is the profit Fulgent Genetics makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. View All Fundamentals
 
Gross Profit  
First Reported
2015-03-31
Previous Quarter
39.8 M
Current Value
23.3 M
Quarterly Volatility
80.1 M
 
Yuan Drop
 
Covid
Check Fulgent Genetics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Fulgent main balance sheet or income statement drivers, such as Discontinued Operations of 49.5 K, Depreciation And Amortization of 33.3 M or Interest Expense of 38.9 M, as well as many exotic indicators such as Price To Sales Ratio of 2.83, Dividend Yield of 0.0186 or PTB Ratio of 0.72. Fulgent financial statements analysis is a perfect complement when working with Fulgent Genetics Valuation or Volatility modules.
  
This module can also supplement Fulgent Genetics' financial leverage analysis and stock options assessment as well as various Fulgent Genetics Technical models . Check out the analysis of Fulgent Genetics Correlation against competitors.
For more information on how to buy Fulgent Stock please use our How to Invest in Fulgent Genetics guide.

Latest Fulgent Genetics' Gross Profit Growth Pattern

Below is the plot of the Gross Profit of Fulgent Genetics over the last few years. Gross profit is a required income statement account that reflects total revenue of Fulgent Genetics minus its cost of goods sold. It is profit before Fulgent Genetics operating expenses, interest payments and taxes. Gross profit is also known as gross margin. It is the profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. Fulgent Genetics' Gross Profit historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Fulgent Genetics' overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 366.9 M10 Years Trend
Slightly volatile
   Gross Profit   
       Timeline  

Fulgent Gross Profit Regression Statistics

Arithmetic Mean120,573,338
Geometric Mean9,850,523
Coefficient Of Variation181.79
Mean Deviation156,354,496
Median10,665,000
Standard Deviation219,192,742
Sample Variance48045.5T
Range776.7M
R-Value0.57
Mean Square Error35069.2T
R-Squared0.32
Significance0.03
Slope27,821,941
Total Sum of Squares672636.4T

Fulgent Gross Profit History

2024179.1 M
202396.6 M
2022366.9 M
2021777.1 M
2020331.9 M
201918.4 M
201810.7 M

Other Fundumenentals of Fulgent Genetics

Fulgent Genetics Gross Profit component correlations

1.00.99-0.90.980.850.660.960.890.96-0.590.890.990.970.970.890.950.610.8-0.3
1.00.99-0.90.990.840.650.950.890.96-0.590.90.980.970.970.890.940.60.8-0.29
0.990.99-0.930.970.820.680.960.870.96-0.60.870.990.980.950.90.950.610.77-0.35
-0.9-0.9-0.93-0.85-0.85-0.83-0.89-0.92-0.790.58-0.87-0.9-0.92-0.89-0.97-0.89-0.82-0.840.15
0.980.990.97-0.850.770.550.890.860.95-0.480.90.940.960.960.870.90.540.78-0.26
0.850.840.82-0.850.770.90.890.930.73-0.60.880.850.730.880.860.890.840.930.02
0.660.650.68-0.830.550.90.780.810.51-0.50.710.70.60.680.80.760.920.830.05
0.960.950.96-0.890.890.890.780.840.93-0.590.810.990.90.90.840.980.640.77-0.39
0.890.890.87-0.920.860.930.810.840.74-0.570.980.850.840.940.970.860.870.970.13
0.960.960.96-0.790.950.730.510.930.74-0.570.750.970.930.890.740.920.390.63-0.51
-0.59-0.59-0.60.58-0.48-0.6-0.5-0.59-0.57-0.57-0.51-0.58-0.52-0.54-0.52-0.56-0.41-0.490.16
0.890.90.87-0.870.90.880.710.810.980.75-0.510.830.840.940.950.820.810.960.16
0.990.980.99-0.90.940.850.70.990.850.97-0.580.830.950.930.850.970.590.75-0.41
0.970.970.98-0.920.960.730.60.90.840.93-0.520.840.950.920.90.90.570.72-0.35
0.970.970.95-0.890.960.880.680.90.940.89-0.540.940.930.920.920.940.680.87-0.13
0.890.890.9-0.970.870.860.80.840.970.74-0.520.950.850.90.920.850.860.920.04
0.950.940.95-0.890.90.890.760.980.860.92-0.560.820.970.90.940.850.630.77-0.37
0.610.60.61-0.820.540.840.920.640.870.39-0.410.810.590.570.680.860.630.910.36
0.80.80.77-0.840.780.930.830.770.970.63-0.490.960.750.720.870.920.770.910.29
-0.3-0.29-0.350.15-0.260.020.05-0.390.13-0.510.160.16-0.41-0.35-0.130.04-0.370.360.29
Click cells to compare fundamentals

About Fulgent Genetics Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Fulgent Genetics income statement, its balance sheet, and the statement of cash flows. Fulgent Genetics investors use historical funamental indicators, such as Fulgent Genetics's Gross Profit, to determine how well the company is positioned to perform in the future. Although Fulgent Genetics investors may use each financial statement separately, they are all related. The changes in Fulgent Genetics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Fulgent Genetics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Fulgent Genetics Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Fulgent Genetics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Gross Profit96.6 M179.1 M
Gross Profit Margin 0.33  0.44 

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Fulgent Genetics is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Fulgent Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Fulgent Genetics Stock. Highlighted below are key reports to facilitate an investment decision about Fulgent Genetics Stock:
Check out the analysis of Fulgent Genetics Correlation against competitors.
For more information on how to buy Fulgent Stock please use our How to Invest in Fulgent Genetics guide.
Note that the Fulgent Genetics information on this page should be used as a complementary analysis to other Fulgent Genetics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.

Complementary Tools for Fulgent Stock analysis

When running Fulgent Genetics' price analysis, check to measure Fulgent Genetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fulgent Genetics is operating at the current time. Most of Fulgent Genetics' value examination focuses on studying past and present price action to predict the probability of Fulgent Genetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fulgent Genetics' price. Additionally, you may evaluate how the addition of Fulgent Genetics to your portfolios can decrease your overall portfolio volatility.
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Bonds Directory
Find actively traded corporate debentures issued by US companies
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Is Fulgent Genetics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Fulgent Genetics. If investors know Fulgent will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Fulgent Genetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.99)
Earnings Share
(5.63)
Revenue Per Share
9.71
Quarterly Revenue Growth
0.041
Return On Assets
(0.03)
The market value of Fulgent Genetics is measured differently than its book value, which is the value of Fulgent that is recorded on the company's balance sheet. Investors also form their own opinion of Fulgent Genetics' value that differs from its market value or its book value, called intrinsic value, which is Fulgent Genetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Fulgent Genetics' market value can be influenced by many factors that don't directly affect Fulgent Genetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Fulgent Genetics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Fulgent Genetics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Fulgent Genetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.